What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Major depressive disorder
Charles B. Nemeroff focuses on Depression, Internal medicine, Psychiatry, Endocrinology and Clinical psychology.
His Depression study combines topics in areas such as Hydrocortisone, Disease and Pediatrics.
His study in the field of Anxiety, Major depressive disorder and Mood disorders is also linked to topics like Child abuse.
His study explores the link between Anxiety and topics such as Mood that cross with problems in Hypothalamic–pituitary–adrenal axis.
His Endocrinology research integrates issues from Neuropeptide and Cerebrospinal fluid.
His study in the fields of Psychopathology under the domain of Clinical psychology overlaps with other disciplines such as Injury prevention.
His most cited work include:
- The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies (2139 citations)
- Pituitary-Adrenal and Autonomic Responses to Stress in Women After Sexual and Physical Abuse in Childhood (1605 citations)
- The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. (1385 citations)
What are the main themes of his work throughout his whole career to date?
Charles B. Nemeroff mostly deals with Internal medicine, Endocrinology, Psychiatry, Depression and Pharmacology.
His study in Internal medicine focuses on Neuropeptide, Cerebrospinal fluid, Central nervous system, Corticotropin-releasing hormone and Hormone.
His work carried out in the field of Endocrinology brings together such families of science as Neurotensin and Receptor.
His Neurotensin study combines topics from a wide range of disciplines, such as Haloperidol, Nucleus accumbens, Neuroscience and Schizophrenia.
His Clinical psychology research extends to Psychiatry, which is thematically connected.
His research in the fields of Antidepressant overlaps with other disciplines such as In patient.
He most often published in these fields:
- Internal medicine (41.89%)
- Endocrinology (30.96%)
- Psychiatry (29.58%)
What were the highlights of his more recent work (between 2012-2021)?
- Psychiatry (29.58%)
- Depression (28.36%)
- Internal medicine (41.89%)
In recent papers he was focusing on the following fields of study:
Psychiatry, Depression, Internal medicine, Major depressive disorder and Clinical psychology are his primary areas of study.
His work in the fields of Psychiatry, such as Mood disorders and Schizophrenia, overlaps with other areas such as Child abuse.
His work on Antidepressant as part of general Depression research is often related to Suicidal ideation, thus linking different fields of science.
His research integrates issues of Placebo, Endocrinology and Oncology in his study of Internal medicine.
His Major depressive disorder research also works with subjects such as
- Escitalopram and related Duloxetine,
- Bioinformatics which connect with Gene.
His research in Clinical psychology focuses on subjects like Neuroimaging, which are connected to Biomarker.
Between 2012 and 2021, his most popular works were:
- Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions (918 citations)
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression (307 citations)
- Paradise Lost: The Neurobiological and Clinical Consequences of Child Abuse and Neglect (279 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
Charles B. Nemeroff mainly investigates Depression, Psychiatry, Internal medicine, Major depressive disorder and Clinical psychology.
Many of his research projects under Depression are closely connected to Suicide prevention with Suicide prevention, tying the diverse disciplines of science together.
His Mood disorders, Bipolar disorder and Schizophrenia study in the realm of Psychiatry connects with subjects such as Child abuse.
Charles B. Nemeroff has included themes like Placebo, Endocrinology and Oncology in his Internal medicine study.
The various areas that he examines in his Major depressive disorder study include Escitalopram, Pharmacogenomics, Electroconvulsive therapy, Cognitive behavioral therapy and Cognitive therapy.
In the subject of general Clinical psychology, his work in Mood is often linked to Early life stress, thereby combining diverse domains of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
